InvestorsHub Logo
Followers 16
Posts 3143
Boards Moderated 1
Alias Born 11/09/2006

Re: None

Monday, 04/05/2021 7:53:30 AM

Monday, April 05, 2021 7:53:30 AM

Post# of 18340
8-K 11/21/12 if accurate.........I'm trying to remember what accomplishments some of these people did for us shareholders and if they were not successful why? If successful then for who? I just don't know? It is clear that Dr. Albitar was smart yet how can he be a consultant for HDC when NEO airs a PR that he now works for NEO and no longer associated with HDC. Did he still consult or was that a mistaken statement by the new interim chairman Joseph McKenzie? Does anyone now if he flubbed up. I know he consulted for free?

ITEM 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 15, 2012, Maher Albitar, M.D. resigned from the Board of Directors of Health Discovery Corporation (the “Company”). Dr. Albitar will continue to serve as a consultant to the Company.

On November 16, 2012, Stephen D. Barnhill, M.D. resigned as Chairman, Director, and interim Chief Executive Officer of the Company. Dr. Barnhill will continue to serve as a consultant to the Company. Joseph McKenzie D.V.M., a current member of the Board, has been appointed Chairman.

Mark A. Moore, Ph.D., 67, Chairman and Chief Executive Officer of SVM Capital, LLC (“SVM Capital”), has been appointed interim Chief Operating Officer of the Company and will serve as the Company’s principal executive officer and principal financial officer. The Company continues the search process for a permanent CEO and Dr. Moore will manage the Company operations during this search process. The Company will pay Dr. Moore a salary of $10,000 per month for his services. In January 2007, SVM Capital was formed as a joint venture between the Company and Atlantic Alpha Strategies, LLC (“Atlantic Alpha”), an absolute return hedge fund, to explore and exploit the potential applicability of the Company’s SVM technology to quantitative investment management techniques. Dr. Moore received a B.A. degree in Science and Philosophy from Florida Atlantic University in 1966. He received a Ph.D. in Philosophy with an emphasis on Value Theory and Logic from the University of Tennessee, Knoxville in 1973. Currently, Dr. Moore is also Chairman of Atlantic Alpha. In addition, Dr. Moore has served as Treasurer and Chairman of Memorial Health University Hospital Foundation as well as a member of the Board of Directors of Memorial Health University, where he is a member of the Investment and Finance Committee. Dr. Moore remains a member of Memorial Foundation Board.

Also, Herbert A. Fritsche, Ph.D. announced his retirement as Senior Vice President and Chief Science Officer of the Company effective December 31, 2012. In addition, Dr. Fritsche will resign from the Board of Directors effective December 31, 2012. Dr. Fritsche will continue his work with the Company as a consultant beginning January 1, 2013.
_______________

I wonder if Herbert's big name was just being used during all the wasted years all of us have seen. Maybe I missed a PR on his credited push to send HDC's share price into the stratosphere back then?